Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

A nonapeptide encoded by human gene MAGE-1 is recognized on HLA-A1 by cytolytic T lymphocytes directed against tumor antigen MZ2-E.

1992 • 694 citations

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.

1995 • 446 citations

Prolongation of Survival in Metastatic Melanoma After Active Specific Immunotherapy With a New Polyvalent Melanoma Vaccine

1992 • 410 citations

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1996 • 398 citations

Partial purification and some properties of BB7.2 a cytotoxic monoclonal antibody with specificity for HLA-A2 and a variant of HLA-A28

1981 • 327 citations

Patterns of care for carcinoma of the prostate gland: results of a national survey of 1984 and 1990.

1995 • 80 citations

Comparison of prostate specific membrane antigen, and prostate specific antigen levels in prostatic cancer patients.

1995 • 70 citations

New strategies for active immunotherapy with genetically engineered tumor cells

1992 • 66 citations

In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy

1995 • 51 citations

Cytotoxic T‐Cell Clones Isolated from Ovarian Tumour Infiltrating Lymphocytes Recognize Common Determinants on Non‐Ovarian Tumour Clones

1993 • 33 citations